The largest database of trusted experimental protocols

59 protocols using anti rhoa

1

Western Blot Analysis of Lung and MLVEC Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
For western blotting, the lung tissues and MLVECs were homogenized in cold RIPA lysis buffer (Beyotime Institute of Biotechnology) containing proteinase and phosphatase inhibitor cocktail (Roche Diagnostics). Equal amounts of protein extract (30-40 µg) were separated by 8-12% SDS-PAGE and transferred onto PVDF membranes (EMD Millipore). After blocking in 5% non-fat dry milk for 2 h at room temperature, the membranes were probed overnight at 4°C with anti-SPHK1 (cat. no. ab71700; 1:500; Abcam), anti-phosphorylated (p)-myosin phosphatase target subunit 1 (p-MYPT1; cat. no. 5163S; 1:1,000; Cell Signaling Technology, Inc.), anti-MYPT1 (cat. no. 2634S; 1:1,000; Cell Signaling Technology, Inc.), anti-RhoA (cat. no. ab187027; 1:3,000; Abcam) and anti-β-actin (cat. no. sc-47778; 1:500; Santa Cruz Biotechnology, Inc.) antibodies. After washing, the membranes were incubated for 1 h at room temperature with horseradish peroxidase-conjugated secondary antibodies (cat. nos. ab6721 and ab6728; 1:5,000; Abcam). The antibody-reactive bands were visualized via an enhanced chemiluminescence western blotting detection system (EMD Millipore). The membranes were visualized using the UVP Bio-Imaging system. Densitometric analysis was performed using Quantity One software (version 4.6; Bio-Rad Laboratories, Inc.).
+ Open protocol
+ Expand
2

Detecting Active Small G-proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were serum-starved overnight and stimulated with LPA. Active small G-proteins were detected by pull-down with GST-RBD and GST-CRIB. Anti-RhoA (2117; Cell Signaling Technology), anti-Rac1 (2320346; Merck Millipore), and anti-Cdc42 (2466; Cell Signaling Technology) against the corresponding small G-protein were used for immunoblotting in this assay. The active and total GTPases were subsequently detected with horseradish peroxidase- (HRP-) conjugated secondary antibody according to the manufacturer's recommendations.
+ Open protocol
+ Expand
3

Immunoblotting for Protein Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used to assess protein levels: anti-RhoA (Cell Signaling Technology), antiphosphate MYPT (EMD Millipore), antiphosphomyosin light chain (MLC; Cell Signaling Technology), anti-MLC (Cell Signaling Technology), and anti-β-actin (Sigma-Aldrich Co.). The secondary antibodies used were horseradish peroxidase-conjugated goat antirabbit and antimouse IgG (Santa Cruz Biotechnology Inc.). Protein concentrations were assayed using the Bio-Rad Protein Assay Dye Reagent (Bio-Rad Laboratories, Hercules, CA, USA). Immunoprecipitates were separated on SDS gels. Samples of total protein (50 µg) were separated using 10% SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose membranes, and incubated with primary antibody. Immunocomplexes were detected using the appropriate horseradish peroxidase-conjugated secondary antibody and observed using a UVP AutoChemi Image and Analysis System (UVP, Upland, CA, USA) with enhanced chemiluminescence (Amersham-Pharmacia International, Piscataway, NJ, USA).
+ Open protocol
+ Expand
4

GTPase Activation Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
GTPase activation was performed according to standard procedures as described elsewhere [25 (link)]. In brief, Cells were harvested in magnesium-containing lysis buffer and the lysates were sonicated for 5 s and centrifuged for 30 min at 18,000×g and 4 °C the Rho/Rac/Cdc42 Assay Reagent Kit (Thermo Scientific, USA) according to the manufacturer’s instructions. The primary antibodies used were anti-RhoA (Cell Signaling Technology, #2117, diluted at 1:1000), and anti-Rac1 (Millipore, 05–389, clone 23A8, diluted at 1:200), anti-Cdc42 (Cell Signaling Technology, #2462, diluted at 1:1000).
+ Open protocol
+ Expand
5

Western Blot Analysis of Cul3 and RhoA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The small fraction of tissue lysates prepared for mass-spectrometry experiments were used for western blotting. On average 10–15 μg of total protein from WT and Cul3+/− cerebral cortex, cerebellum or hippocampus were resolved by SDS-PAGE and transferred onto PVDF Immobilon-P membranes (Millipore). After blocking with 5% nonfat dry milk in 1× TBS with 0.1% Tween-20 (TBST) for 1 h at room temperature, membranes were first probed overnight with the appropriate primary antibodies in 3% BSA in TBST, and then after 1 h of incubation with corresponding host specific HRP-conjugated secondary antibody (Abcam). Membranes were developed using the EZ-ECL chemiluminescence detection kit (Denville Scientific). The following primary antibodies were used: anti-Cul3 (1:1000; Cell Signaling), anti-RhoA (1:1000; Cell Signaling), and anti-Gapdh (1:5000; Sigma Aldrich) as a loading control. Quantification was performed by densitometry with ImageJ software. Western Blot images for quantification of Cul3, total RhoA and active RhoA are shown in the Supplementary Fig. S18.
+ Open protocol
+ Expand
6

Reagents and inhibitors for RhoA, Cdc42, Rac1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti RhoA, Cdc42, Rac1, and β-tubulin antibodies were purchased from Cell Signaling Technology (USA). ST1937 and SB258585 were obtained from Tocris (Bristol, UK). C3 transferase was from Cytoskeleton Inc. (USA). Y-27632 was a product of Invitrogen (USA). PP2, H89, and PD98059 were products of Calbiochem (USA). 5-HT and other chemicals were purchased from Sigma (USA). Protease inhibitor mixture were from BioVision (USA).
+ Open protocol
+ Expand
7

Western Blot Analysis of Cellular Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole cell lysates or immunoprecipitated proteins were separated by SDS-PAGE electrophoresis and transferred to PVDF membranes (Westran® Clear Signal). The membranes were blocked with 5% milk or bovine serum albumin (BSA) in TBS-0.1% Tween20 (TBS-T) and subsequently immunoblotted overnight at 4°C. The membranes were then probed with horseradish peroxidase-conjugated secondary antibodies (Jackson Immunoresearch, Beckman Coulter, France) followed by SuperSignal West Pico Substrate (Thermo Scientific). Chemiluminescence was detected with a Fuji LAS-4000 luminescent image analyzer. The antibodies used in this study were as follows: anti-actin (Sigma-Aldrich), anti-HA (Covance, Eurogentec, France), anti-pan-CD44, anti-phosphoTrkA (Tyr-674/675), anti-p115-RhoGEF, anti-ROCK1, anti-RhoA, anti-RhoC, anti-phosphoAkt (Ser-473), and anti-pan-Akt (Cell Signaling Technologies).
+ Open protocol
+ Expand
8

Western Blot Analysis of ARHGAP35, E-cadherin and RhoA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Briefly, total proteins were extracted using a radio-immunoprecipitation (RIPA) lysis buffer supplemented with protease and phosphatase inhibitors. Western blot analysis was then performed according to the standard procedures, as previously described. The antibodies used were as follows: Anti-ARHGAP35 (cat. no. 2860), anti-E-cadherin (cat. no. 3195S; both from Cell Signaling Technology, Inc.), anti-RhoA (cat. no. ab187027; Abcam), anti-GTP-RhoA (cat. no. ARH05; Cytoskeleton, Inc.) and anti-β-actin (cat. no. A2228; clone AC-74; MilliporeSigma).
+ Open protocol
+ Expand
9

Signaling Mechanisms in Vascular Smooth Muscle

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vascular smooth muscle cells were treated with non-formylated peptides or F-MIT (20 min, 10 μM). After treatment, cells were washed with an ice-cold phosphate-buffered saline (PBS) solution. Complete Lysis-M, including phosphatase inhibitor cocktail (PhosSTOP) (both Roche, Indianapolis, IN, USA), was then applied to each plate and allowed to remain on ice for 30 min. Cells were then harvested. Protein concentration was first determined and then equal quantities of protein were loaded into polyacrylamide gels (8–12%) and separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Gels were then transferred to polyvinylidene difluoride (PVDF) membranes (Thermofisher). The membranes were blocked with 5 % nonfat dry milk and incubated overnight at 4°C with primary antibodies raised against anti-RhoA (1:2000; Cell Signaling), ROCK (1:1000; Cell signaling), L-type calcium channel (Cav 1.2, 1:500, abcam), PKCα (1:1000, BD Bioscience), AHNAK (1:1000, Thermofisher), pMYPT1Thr696 (1:1000, Cell Signaling), MYPT1 (1;1000, BD Transduction). β-actin (1: 40:000, Sigma) was used as the loading control. Densitometric analysis was performed by Un-Scan-It (Version 6.1) (Silk Scientific, USA).
+ Open protocol
+ Expand
10

Regulation of p120-catenin by Src

Check if the same lab product or an alternative is used in the 5 most similar protocols
The anti-pY228-p120-catenin antibody was purchased from BD Bioscience (#612537). The anti-GTP-RhoA antibody was purchased from NewEast (#26904). The anti-p120-catenin (#59854), anti-snail (#3879), anti-c-myc (#9402), anti-E-cadherin (#14472), anti-β-actin (#4970), anti-RhoA (#2117), anti-ROCK1 (#4035), and anti-Src (#2109) antibodies were purchased from Cell Signaling Technology.
The full-length coding regions of human p120-catenin were cloned into pCDNA3.1 vector by Genephama (Shanghai, China), which was used for overexpressing p120-catenin in SW480 cells. The mutation of Y228F and Y228E was generated based on site-directed mutagenesis strategy by Genephama. The c-Src construct was purchased from Addgene (#42205). All plasmid constructs were verified by DNA sequencing. Knockdown of Src was achieved by using specific siRNA from Santa Cruz Biotechnology (#sc-29228).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!